Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 weeks.

Evita Solutions, maker of the new generic mifepristone, says its mission is to \

The move has infuriated conservatives who've sought to curb access to medication abortion.